Pradžia › Židinė alopecija › Kalifornija
Židinė alopecija klinikiniai tyrimai Kalifornija
10 tyrimai dėl Židinė alopecija ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatology Research Associates - Los Angeles /ID# 282821, Los Angeles
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Center For Dermatology Clinical Research, Inc., Fremont
- Northridge Clinical Trials, Northridge
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita
Renkami dalyviai2 fazė
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Doc1 Healthcare Systems, Brea
- University of California - Irvine, Irvine
- Gavin Herbert Eye Institute, Irvine
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
- University of California, Irvine, Irvine
- University of California San Diego, San Diego
Renkami dalyviai2 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-02 · NCT05866562A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Exalt Clinical Research /ID# 283814, Chula Vista
- First Oc Dermatology /ID# 259220, Fountain Valley
- Dermatology Research Associates /ID# 258033, Los Angeles
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 12 iki 63 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06012240Regeneron AA Multicenter (Dupilumab)
- University of California, Irvine, Irvine
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-17 · NCT05551793A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- California Dermatology & Clinical Research Institute, Encinitas
Renkami dalyviai3 fazė
Amžius nuo 6 iki 14 · Visoms lytims · Atnaujinta 2026-04-28 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Clinical Trial Research Institute, Thousand Oaks
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-03-04 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Kern Research Inc., Bakersfield
- Center For Dermatology Clinical Research Inc., Fremont
- Dermatology Research Associates, Los Angeles
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-01-28 · NCT07133308Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.